Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Atherosclerosis Development
100%
Diabetes Mellitus Model
100%
Darapladib
100%
Type 2 Diabetes Melitus
100%
In Vivo Rat
100%
Early Atherosclerosis
100%
Inflammation Level
100%
Oxidized Low-density Lipoprotein (ox-LDL)
50%
Platelet-activating Factor
50%
Interleukin-6
33%
In Vivo Model
33%
Inducible Nitric Oxide Synthase
33%
Adipose Tissue Thickness
33%
Perivascular Adipose Tissue
33%
Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
33%
Oxidative Stress
16%
Blood Glucose
16%
Experimental Facility
16%
Tumor Necrosis Factor-α
16%
Insulin Resistance
16%
Time-to-treatment
16%
Lipid Profile
16%
ANOVA Test
16%
Inflammation Markers
16%
Tissue Damage
16%
Group Design
16%
Vascular Inflammation
16%
Plasma Parameters
16%
Anti-inflammation
16%
Diabetes Type 1
16%
Selective Inhibitor
16%
Inflammatory Effects
16%
LDL Levels
16%
Atherogenesis
16%
Oxidized Fatty Acids
16%
Normal Type
16%
Lysophosphatidylcholine
16%
Insulin Plasma
16%
Anti-inflammatory Role
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Inflammation
100%
Atherosclerosis
100%
Darapladib
100%
Thrombocyte Activating Factor
42%
Interleukin 6
28%
Inducible Nitric Oxide Synthase
28%
1 Alkyl 2 Acetylglycerophosphocholine Esterase
28%
Fatty Acid
14%
Tumor Necrosis Factor
14%
Insulin Resistance
14%
Anti-Inflammatory Drug
14%
Vasculitis
14%
Anti-Inflammation
14%
Tissue Injury
14%
Atherogenesis
14%
Oxidized Low Density Lipoprotein
14%
Lysophosphatidylcholine
14%